Clinical Trials Sponsored by Jean-Paul BERESSI, MD, Department of diabetology, Versailles Hospital
Total 1 results
-
Versailles HospitalBernard LIVAREK, MD, Cardiology department, Versailles Hospital; Jean-Paul... and other collaboratorsUnknown
Sponsors and Collaborators
- Caritas Freetown
- The Fifth Affiliated Hospital of Zunyi Medical College
- Alberta Children's Hospital, Calgary, Canada
- Diego Hernan Giunta, MD
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- Societa Italiana di Endoscopia Digestiva
- Rui-hua Xu, MD, PhD
- ProteoSys AG
- Elim Pediatric Pharmaceuticals Inc.
- CRMBM-CEMEREM
- Cardresearch
- Donders Institute for Brain, Cognition and Behavior
- San MediTech(Huzhou)Co.,Ltd.
- AMTC & Associates
- University Medical Center Goettingen
- Victor Montori
- Fondren Orthopedic Group L.L.P.
- Celtaxsys Aus Pty Limited
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- Norsk Proteinintolerance, Norway
- View Full List
Medical Conditions
- Autologous Haematopoietic Stem Cell Transplant
- Secondary Hypertension to Endocrine Disorders
- Pulmonary Invasive Aspergillosis
- Enlarged Uterus
- Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
- High Perinatal Mortality
- Role of Vitamin D in IVF for Better Outcome
- Pancytopenia Due to Chemotherapy
- Urinary Tract Carcinoma
- Using Imagery to Maintain Muscle Mass Gains in the Quadriceps
- Stage II Vulvar Cancer
- Stereotype-threat
- Airway Obstruction
- Raynaud Secondary to Other Autoimmune Disease
- EHMT1
- Smith-Lemli-Opitz Syndrome
- Global Health
- Advanced Gastric Cancer With Serosal Invasion
- Caffeine Dosage
- Gait Variability; Elders; Fall; Re-education
- View Full List
Drug Interventions
- SERETIDE Diskus
- Insulin
- Cytarabine ARA-C
- Topotecan
- Bortezomib/dexamethasone
- Lamivudine
- Oxycodone, fentanyl
- Atezolizumab
- Cetrorelix 78 mg + 78 mg
- PF-00868554
- Indoximod
- Polyethylene glycol 3350
- Flibanserin 100 mg dose every evening
- Enzalutamide, Abiraterone
- Mupirocin Calcium
- Methotrexate
- Epimedium Prenylflavonoids Extract
- Ruxolitinib
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- View Full List
CROs by country
- Contract Research Organizations in Armenia
- Contract Research Organizations in Benin
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Kenya
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Singapore
- Contract Research Organizations in South Africa
- Contract Research Organizations in Switzerland
- Contract Research Organizations in Thailand
- Contract Research Organizations in Tunisia
- CRO list by country